Ischemic Stroke
Conditions
Interventions
test group:Baiyu Ginkgolide injection
Sponsors
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
No minimum to 100 Years
Inclusion criteria
Inclusion criteria: 1. patients accord to diagnostic standards on western medical ischemic stroke; 2. patients accord to diagnostic standards on Chinese medical attack to meridians; 3. 7 days to 6 months after invasion; 4. patients accord to differentiation standards on blood stasis syndrome; 5. patients must be voluntary to be subjected and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. patients accompany with unconsciousness or severe dementia; 2. patients allergic to Ginkgo biloba drugsethanol or glycerin; 3. patients who are pregnant,nursing or planning for pregnancy; 4. patients with hemorrhagic cerebral infarction and cerebral arteritis; 5. patients with cerebral embolism caused by cerebral tumor,trauma,parasitosis,rheumatic heart disease,coronary heart disease and other heart disease complicated with atrial fibrillation; 6. ALT, AST>=2.5 times of upper limit of normal, Cr>=1.5 times of upper limit of normal; 7. patients with insanity or not suitable for clinical trial under doctors' consideration; 8. patients with hemorrhagic tendency, severe bleeding within 3 months, PLT under lower limit of normal or APTT above 3 seconds of control value; 9. patients who have participated in other clinical trial in 1 month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse Events;BP, temperature, breath, heart rate;blood routine, urine routine, stool routine +occult;ALT, AST, TBIL, ALP, garma-GT, BUN, Cr, beta2-MG;CK, CK-MB;PT, APTT, TT, FIB, D-Dimer;ECG; | — |
Countries
China
Contacts
Public ContactBaohe Wang
Outcome results
None listed